UNSPSC 85891913: High dose rate (hdr) brachytherapy of head and neck using other isotope

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of head and neck using other isotope. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DW119YZ

UNSPSC 85891913 High dose rate (HDR) brachytherapy of head and neck using other isotope is a Commodity code that shows no relevant recent state and local procurement activity. The single recent opportunity posted under this code—the County of Santa Clara Health System's July 7, 2026 solicitation (RFSQHHSFY270052) for temporary health professional staffing services with a response date of October 7, 2026—is unrelated to the code's nominal scope. The Santa Clara solicitation targets ancillary clinical staffing across audiology, cardiology, diagnostic imaging, gastroenterology, ophthalmology, orthopedic, respiratory care, sterile processing, surgical and operating room, therapy, and related non-nursing positions; it does not address brachytherapy, radiotherapy isotopes, head and neck oncology, or radiation oncology services of any kind. The mismatch suggests either a coding error in the state and local procurement system or that this particular code sees minimal relevant activity in the recent solicitation pipeline.

Without additional opportunities tagged to this code, a state and local business development professional would have no basis to evaluate buying patterns, issuing-body concentration, or geographic spread relevant to HDR brachytherapy services. The code tier sits at the Commodity level—the most granular taxonomy level—and should correspond to highly specialized clinical radiation therapy equipment and services, yet the recent posting record does not support that scope. Practitioners pursuing brachytherapy or radiation oncology work should verify code assignments in state and local RFP databases directly and consider whether this code is actively used by health systems, cancer treatment centers, university medical centers, or specialty hospital networks in their target jurisdictions.